Showing results (1111-1120 of 1,175) with videos related to

Sort By:
Pageof 118
Nature Human Behaviour|April 2, 2026
A systematic review of the global and regional estimates of the prevalence of sexual violence against childrenXiangming Fang, Jingru Ren, Jian Kang, et al.
MMWR. Morbidity and Mortality Weekly Report|October 6, 2022
Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021Ariana Perez, Joana Y Lively, Aaron Curns, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Impact of Endoluminal Flow Diverter Number on Aneurysm Treatment Outcomes: A Multicenter StudyJustin E Vranic, Pablo Harker, Christopher J Stapleton, et al.
Neurosurgery|October 8, 2021
Flow Diversion for Middle Cerebral Artery Aneurysms: An International Cohort StudyJose Danilo Bengzon Diestro, Nimer Adeeb, Mahmoud Dibas, et al.
Vaccine|January 10, 2026
Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness-IVY network, January 24, 2022-September 1, 2024Elizabeth J Harker, Nathaniel M Lewis, Cassandra A Johnson, et al.
Journal of Computer Assisted Tomography|September 14, 2023
The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter StudyJustin E Vranic, Pablo Harker, Christopher J Stapleton, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Physical Review Letters|April 2, 2016
Direct Evidence of Octupole Deformation in Neutron-Rich ^{144}BaB Bucher, S Zhu, C Y Wu, et al.
BMC Biology|August 19, 2022
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140Mohammed Ghiboub, Jan Koster, Peter D Craggs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and LymphomaDavid T Teachey, Meenakshi Devidas, Brent L Wood, et al.
Pageof 118